These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7531681)

  • 21. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin's lymphomas of small lymphocytes.
    de Leon ED; Alkan S; Huang JC; Hsi ED
    Mod Pathol; 1998 Nov; 11(11):1046-51. PubMed ID: 9831200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
    de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E
    Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implication of cyclin D1 in malignant lymphoma.
    Callanan M; Leroux D; Magaud JP; Rimokh R
    Crit Rev Oncog; 1996; 7(3-4):191-203. PubMed ID: 9258602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative measurement of cyclin D1 mRNA, a potent diagnostic tool to separate mantle cell lymphoma from other B-cell lymphoproliferative disorders.
    Brizova H; Kalinova M; Krskova L; Mrhalova M; Kodet R
    Diagn Mol Pathol; 2008 Mar; 17(1):39-50. PubMed ID: 18303407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PRAD1 gene over-expression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma.
    Oka K; Ohno T; Kita K; Yamaguchi M; Takakura N; Nishii K; Miwa H; Shirakawa S
    Br J Haematol; 1994 Apr; 86(4):786-91. PubMed ID: 7918073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement.
    Williams ME; Swerdlow SH
    Ann Oncol; 1994; 5 Suppl 1():71-3. PubMed ID: 8172823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In situ hybridization detection of cyclin D1 mRNA in centrocytic/mantle cell lymphoma.
    Williams ME; Nichols GE; Swerdlow SH; Stoler MH
    Ann Oncol; 1995 Mar; 6(3):297-9. PubMed ID: 7612496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCL6 rearrangement in a patient with mantle cell lymphoma.
    Miura I; Ohshima A; Chubachi A; Nimura T; Komatsuda A; Utsumi S; Saito M; Machii T; Nakamura S; Seto M; Miura AB
    Ann Hematol; 1997 May; 74(5):247-50. PubMed ID: 9200999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
    Dunphy CH; Perkins SL
    Arch Pathol Lab Med; 2001 Apr; 125(4):513-8. PubMed ID: 11260626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcl-6 protein expression by follicle center lymphomas. A marker for differentiating follicle center lymphomas from other low-grade lymphoproliferative disorders.
    Raible MD; Hsi ED; Alkan S
    Am J Clin Pathol; 1999 Jul; 112(1):101-7. PubMed ID: 10396291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical detection of E2F-1 in non-Hodgkin's lymphomas: a survey of 124 cases.
    Lai R; Medeiros LJ; Coupland R; McCourty A; Brynes RK
    Mod Pathol; 1998 May; 11(5):457-63. PubMed ID: 9619599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin D1 expression in B-cell lymphomas.
    Gladkikh A; Potashnikova D; Korneva E; Khudoleeva O; Vorobjev I
    Exp Hematol; 2010 Nov; 38(11):1047-57. PubMed ID: 20727381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
    Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
    Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphologic diagnosis of leukaemic B-lymphoproliferative disorders and the role of cyclin D1 expression.
    Oertel J; Kingreen D; Busemann C; Stein H; Dörken B
    J Cancer Res Clin Oncol; 2002 Apr; 128(4):182-8. PubMed ID: 11935308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibody against PRAD1/cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus.
    Banno S; Yoshikawa K; Nakamura S; Yamamoto K; Seito T; Nitta M; Takahashi T; Ueda R; Seto M
    Jpn J Cancer Res; 1994 Sep; 85(9):918-26. PubMed ID: 7961120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bcl-2 protein in centrocytic lymphoma; a paraffin section study.
    Swerdlow SH; Utz GL; Williams ME
    Leukemia; 1993 Sep; 7(9):1456-8. PubMed ID: 8371594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Instances of mantle cell lymphoma morphologically mimicking other subtypes of B-cell lymphoid proliferation.
    Schuetz MJ; Zafar N; Vasef MA
    South Med J; 2009 Apr; 102(4):369-73. PubMed ID: 19279536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimized cyclin D1 immunoperoxidase staining in mantle cell lymphoma.
    Korin HW; Schwartz MR; Chirala M; Younes M
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):57-60. PubMed ID: 10937050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow.
    Vasef MA; Medeiros LJ; Koo C; McCourty A; Brynes RK
    Am J Clin Pathol; 1997 Sep; 108(3):302-7. PubMed ID: 9291459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.